Table:
begin	end	state
1	11	cytoplasmic
12	33	transmembrane
34	44	non-cytoplasmic
45	69	transmembrane
70	95	cytoplasmic
96	118	transmembrane
119	152	non-cytoplasmic
153	172	transmembrane
173	181	cytoplasmic
182	204	transmembrane
205	223	non-cytoplasmic
224	248	transmembrane
249	260	cytoplasmic
261	286	transmembrane
287	305	non-cytoplasmic
306	330	transmembrane
331	350	cytoplasmic
351	373	transmembrane
374	388	non-cytoplasmic
389	410	transmembrane
411	430	cytoplasmic
431	451	transmembrane
452	453	non-cytoplasmic

Input:
>WP_011815179.1 NCBI__GCF_000015585.1:WP_011815179.1
MKDLRQSIHGEWGSRWAFILAATGSAVGLGNIWRFPYVVGEYGGGAFILIYLACILAIGI
PVMMAEILIGRRGRQSPINTMRALPAEFGAGRWWQILGWLGVIAGFLVLSFYSVVAGWSL
AYVPYTAAGTFTGTETSQVEAIFNDLLASPWQMLFWHTVFMGATAFIVLRGVQNGLERAV
RLLMPILFLLLLVMVGYGMGAGAFVEAMDFMFSPDFSAIGGDAVLVAMGQAFFTLSLGLG
AIMAYGSYLSKRSSIPGNSGLIAGADTVIALLAGLAIFPIVLAAGLDPDSGPGLVFVTLS
YGFGQMPLGALFGTLFFLLLSFAALTSAISIMEPATAYLVETRGWKRPKAAAAVAAAAWL
VGIGSLLAFNVWAGFTIAGLNFQELAEYLSTSVMLPLGGLLMALFAGWVLPRSVTTEELA
LPDWVYRGWLVLVRFVVPAAILVVFANSLGLLG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server